Prelude Capital Management, LLC Enzo Biochem Inc Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$2.86 - $3.61 $12,870 - $16,245
-4,500 Reduced 9.0%
45,500 $144,000
Q1 2021

May 17, 2021
SELL
$2.61 - $4.08 $130,500 - $204,000
-50,000 Reduced 50.0%
50,000 $172,000
Q3 2020

Nov 16, 2020
BUY
$2.02 - $3.02 $202,000 - $302,000
100,000 New
100,000 $211,000
Q2 2018

Aug 14, 2018
SELL
$5.06 - $6.78 $7,529 - $10,088
-1,488 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$5.43 - $8.36 $8,079 - $12,439
1,488 New
1,488 $8,000

Others Institutions Holding ENZ

# of Institutions
48
Shares Held
15.5M
Call Options Held
2.3K
Put Options Held
0
View Full List

About ENZO BIOCHEM INC

ENZ Quotes by TradingView
  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $33.1M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email